1. IL-12: a promising adjuvant for cancer vaccination

   • Johanna E. Portielje
   • Jan Gratama
   • Wim H. Kruit

   Review Pages: 133 - 144

2. Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside

   • Saroj Basak
   • Brigitte Birebent
   • Dorothee Herlyn

   Original Article Pages: 145 - 154

3. A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer

   • Yukio Iwashita
   • Kouichirou Tahara
   • Seigo Kitano

   Original Article 06 February 2003 Pages: 155 - 161

   

4. Melphalan-induced up-regulation of B7–1 surface expression on normal splenic B cells

   • Manjula Donepudi
   • Vladimir M. Jovasevic
   • Margalit B. Mokyr

   Original Article Pages: 162 - 170

5. Analysis of in vitro immunization: generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells

   • Alexey L. Glazyrin
   • June Kan-Mitchell
   • Malcolm S. Mitchell

   Original Article Pages: 171 - 178

6. Comparison of the efficacy of local treatment of equine sarcoids with IL-2 or cisplatin/IL-2

   • T. J. P. Spoormakers
   • W. R. Klein
   • W. Den Otter

   Original Article 04 February 2003 Pages: 179 - 184

   

7. Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody

   • Chuanli Zhao
   • Max Morgan
   • David W. Hoskin

   Original Article Pages: 185 - 193

8. Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties

   • Jörg Westermann
   • Ida J. Körner
   • Antonio Pezzutto

   Original Article Pages: 194 - 198